Status
Conditions
Treatments
About
This is an observational, national, retrospective study consisting of pediatric patients with advanced (spread or unremoveable) melanoma identified in the DMTR in the Netherlands
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
For more information regarding Bristol-Myers Squibb Clinical Trials, please visit www.BMSStudyConnect.com.
Inclusion Criteria:
Exclusion Criteria:
-Participation in a clinical trial within the past 4 weeks prior to first dose with ipilimumab or concurrently
Other inclusion/exclusion criteria apply
10 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal